Hadar Ilan (CIK 1727727) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy SLXN (10,000 shares), Buy SLXN (64,350 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Silexion Therapeutics Corp (SLXN) | Chairman and CEO | Buy | 10,000 | $0 |
| 2026-02-23 | Silexion Therapeutics Corp (SLXN) | Chairman and CEO | Buy | 64,350 | $0 |
Source: SEC Form 4 filings · as of 2026-06-08